Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1)

Sarcomas are malignant tumors accounting for a high percentage of cancer morbidity and mortality in children and young adults. Surgery and radiation therapy are the accepted treatments for most sarcomas; however, patients with metastatic disease are treated with systemic chemotherapy. Many tumors di...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Marco, Peinado-Serrano, Javier, Garcia-Heredia, Jose Manuel, Felipe-Abrio, Irene, Tous, Cristina, Ferrer, Irene, Martin-Broto, Javier, Saez, Carmen, Carnero, Amancio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341855/
https://www.ncbi.nlm.nih.gov/pubmed/27563810
http://dx.doi.org/10.18632/oncotarget.11475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341855/
https://www.ncbi.nlm.nih.gov/pubmed/27563810
http://dx.doi.org/10.18632/oncotarget.11475

Ejemplares similares